Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TDF
7626
Templeton Dragon Fund
TDF
$274M
| $740K | ﹤0.01% |
51,896
+2,188
| +4% | +$27.7K |
|
|
WEBR
7627
CALL
DELISTED
Weber Inc.
WEBR
| $740K | ﹤0.01% |
102,700
+12,700
| +14% | +$106K |
|
|
IEIH
7628
DELISTED
iShares Evolved U.S. Innovative Healthcare ETF
IEIH
| $740K | ﹤0.01% |
22,493
+6,571
| +41% | +$216K |
|
7629
Douglas Elliman
DOUG
$171M
| $739K | ﹤0.01% |
161,998
+85,283
| +111% | +$472K |
|
|
GMS
7630
CALL
DELISTED
GMS Inc
GMS
| $739K | ﹤0.01% |
16,600
-27,300
| -62% | -$1.3M |
|
|
FIVA
7631
Fidelity International Value Factor ETF
FIVA
$605M
| $738K | ﹤0.01% |
+36,512
| New | +$804K |
|
|
SII
7632
PUT
Sprott
SII
$3.03B
| $738K | ﹤0.01% |
21,300
-6,100
| -22% | -$255K |
|
|
TMHC
7633
CALL
DELISTED
Taylor Morrison
TMHC
| $738K | ﹤0.01% |
31,600
+4,200
| +15% | +$111K |
|
7634
CALL
Core Laboratories
CLB
$575M
| $737K | ﹤0.01% |
37,200
+16,000
| +75% | +$425K |
|
7635
iShares US Insurance ETF
IAK
$572M
| $737K | ﹤0.01% |
+8,888
| New | +$769K |
|
|
CHX
7636
CALL
DELISTED
ChampionX
CHX
| $736K | ﹤0.01% |
37,100
-129,800
| -78% | -$2.93M |
|
7637
CALL
Holley
HLLY
$376M
| $736K | ﹤0.01% |
70,100
-22,300
| -24% | -$243K |
|
7638
PUT
Paysafe
PSFE
$334M
| $736K | ﹤0.01% |
31,458
-3,234
| -9% | -$104K |
|
|
MGI
7639
CALL
DELISTED
MoneyGram International, Inc. New
MGI
| $736K | ﹤0.01% |
73,600
-46,900
| -39% | -$472K |
|
|
SHLX
7640
PUT
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $736K | ﹤0.01% |
52,300
-33,900
| -39% | -$478K |
|
|
SOVO
7641
CALL
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $735K | ﹤0.01% |
46,300
+34,000
| +276% | +$494K |
|
|
AGEN
7642
CALL
Agenus
AGEN
$340M
| $734K | ﹤0.01% |
19,274
+8,417
| +78% | +$306K |
|
7643
Blackbaud
BLKB
$2.01B
| $734K | ﹤0.01% |
12,637
+7,870
| +165% | +$457K |
|
7644
DMC Global
BOOM
$146M
| $734K | ﹤0.01% |
40,679
+12,629
| +45% | +$310K |
|
7645
CALL
Carriage Services
CSV
$545M
| $734K | ﹤0.01% |
18,500
-44,200
| -70% | -$1.91M |
|
7646
CALL
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$391M
| $734K | ﹤0.01% |
12,300
+400
| +3% | +$28.8K |
|
7647
PUT
Aspen Aerogels
ASPN
$464M
| $733K | ﹤0.01% |
74,200
+4,000
| +6% | +$80.7K |
|
|
EB
7648
CALL
DELISTED
Eventbrite
EB
| $733K | ﹤0.01% |
71,400
+18,800
| +36% | +$224K |
|
7649
PUT
Ionis Pharmaceuticals
IONS
$9.91B
| $733K | ﹤0.01% |
19,800
-6,600
| -25% | -$249K |
|
|
BTRS
7650
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $733K | ﹤0.01% |
147,226
-518,273
| -78% | -$2.98M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.